PFE 37: Boring but good Risk/Reward in a dangerous market PFE is an enormously profitable company that is not in fashion with the momo crowd or the new kids chasing sexy names. It is however an A+ company with staying power and good dividend yield, a better alternative to bonds in today's near-zero interest rate. As SPY correction is highly likely, it is perhaps a place to park some cash.
Also, the market has shown some interest in routing into real economy stocks (with real revenue and profit). TGT, WMT, GE for instance.
Technically it has turned upwards, after a sharp and quick sell-off from 43, after all the covid vaccine news. 1st Target is 40.50
To be long around 37 or sell PCS of 37/33. If needed lunch money, one could also sell ATM weekly calls that give out a 2% weekly premium.
This is a plan, obviously not any sort of advice.
PFE
Pfizer - So much HYPE but no price actionSo much hype around PFE but no price action. I still think its a $75-80 stock but we will get there one of two ways shown on the chart. They will be getting a F*uck ton of cash in their pockets very soon
Buy at $35 would be great, anything below $35 would be a steal
7 day scare windowThe vaccine stocks didn't explode this week as some of us holding the stocks were hoping for. Either the news was priced in for some stocks, or (as I believe is the case for TMO), it needs another catalyst to really jump back into its bullish channel (green channel -- which has a possible target of 530 - 560!)
I have updated the cycles for TMO and think it sits a bit better in the updated cycle analysis. TMO is in a tight wedge at the moment, but today or tomorrow should give some indication which side it will break towards.
7 Days Risky Window
I hate to say it, but I am seeing this window with a number of stocks since over a month. Seeing now that indexes are over-extended and are just hanging on the stimulus news, I see a potential for a dip over the coming 7 days. The red arrows track this risk. This is only for the near term, as I see TMO bouncing off the 100MA and moving back up as vaccine news and earnings reports near towards January.
Good luck!
NYSE:PFE Pfizer stock price forecast, Buy Breakout, Target 68.45Pfizer (NYSE: PFE)
Trade : Buy Breakout
Entry : 42.84
Target : 68.45 (25.61, +59.78%)
Stop : 37 (-5.84, -13.63%)
Posted on Sunday, December 13, 2020
Note : Pharmaceutical stocks are drawing attention in connection with the COVID-19 (Coronavirus disease 2019) vaccine. Pfizer is one of them. There is no COVID-19 vaccine yet that everyone recognize the efficacy, and it is not known how long it will take. In other words, the prices of pharmaceutical stocks related to the COVID-19 vaccine could not be assured. Pfizer stock prices fell after hitting the resistance line of 42.84. If they strongly break out that price line again, it would be a sign of rise. In that case, the next resistance(target) could be 56.12 and 68.45. If the pharmaceutical market is very strong, we may see 99 or so. It would be better to find opportunities to buy when its stock price breaks out 42.84.
PFE Pfizer retracement completed. Buy opportunity?I warned you about the retracement in the last post:
Look, it`s not trading advice, but the retracement of Pfizer seems completed and now it`s ready for another leg up!
They`ve invented the most important vaccine of out time, let`s not diminish their merits.
If you are interested to test some amazing BUY and SELL INDICATORS, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
PFE PFIZER INCNote to myself, is not investment advice
We can see that, PFE break channel for downward than turned itself into a flag.
After a while, it is possible to see Cup-Hande formation. But not today.. Now we need to wait about break some Fibonacci levels, if break flag.
AFTER FLAG FORMATION
Stop loss: 37,26
Target 1: 39,49 (short-term)
Target 2: 42,66 (mid-term)
Target 3: 46,7 (long-term)
PFE sell CALL 38(covered call 41) 13 nov $.35 pro: got a confirPFE sell CALL 38(covered call 41) 13 nov $.35
pro: got a confirmation daily drop froim weekly
supply 38. so taken the entry after observing
the dosi candle and then next day price
dropping.
risk:( 41-38 = 300$)
max gain=35$
5oct2020
expiry day: 8
PFE Pfizer GOING LOWERFrom the chart, there are 2 things that concern me :
1 - The bearish cross on the CMF (Chaikin Money Flow Indicator)
Chaikin Money Flow (CMF) is a technical analysis indicator used to measure Money Flow Volume over a set period of time. Money Flow Volume is a metric used to measure the buying and selling pressure of a security for single period. CMF then sums Money Flow Volume over a user defined look-back period. Chaikin Money Flow's Value fluctuates between 1 and -1. CMF can be used as a way to further quantify changes in buying and selling pressure and can help to anticipate future changes and therefore trading opportunities.
2 - The market gaps
There is still a gap at $34 and market gaps are usually filled. Not even to mention the huge gap that had just occurred after the news of a successful vaccine candidate.
PFE has exhibited high volatility during the past few months and each high is always followed by a huge sell of. It's like PFE just can't get ahead.
That being said, if you're looking to buy PFE (because viagra isn't going anywhere), I'd be counting on the market gap at $34 as an entry point.
Please support me by hitting like,
wishing you successful trading!
Best Regards,
Ev
NVAX STOCKS DUMPED, DOWNTREND CONTINUESEarlier this year there was the question : How do you invest in Coronavirus vaccine stocks?
Now, we have the answer : YOU DONT.
Chart looking bleak, and the support lines are weak. This could be due to a few reasons:
- Lack of MAINSTREAM updates
- NVAX actually has no other vaccines
- Market volatility due to covid and elections
- Investors are seeking less riskier gains and getting out of stocks that do not look promising
Other than the above, we have seen strange behavior with stocks of companies in the race.
A few examples:
PFE Pfizer stock not responding to numerous huge injections from government
REGN Regeneron stocks hardly responding to Trump pimp
GILD Gilead even FALLING after being the first company world wide to receive FDA approval for remdesivir as a treatment.
AZN Astrazeneca in conjunction with Oxford has a trail candidate dead but stocks remain largely unaffected
I think NVAX has potential in the long run, long term I remain bullish for the company fundamentally, but not for an investment choice right now. In fact I'd say that no vaccine stock is a good investment right now. The way the market reacts to news is too unpredictable and the future remains uncertain.
Hit like if you found this insightful and helpful
Thanks, Ev